about
Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for SchistosomiasisA call to strengthen the global strategy for schistosomiasis and soil-transmitted helminthiasis: the time is nowPoint-of-Care Ultrasound Assessment of Tropical Infectious Diseases--A Review of Applications and Perspectives.High burden of Schistosoma mansoni infection in school-aged children in Marolambo District, Madagascar.Cross-sectional study of the burden of vector-borne and soil-transmitted polyparasitism in rural communities of Coast Province, Kenya.Measuring fitness of Kenyan children with polyparasitic infections using the 20-meter shuttle run test as a morbidity metricEndomyocardial fibrosis (EMF) in a Ugandan child with advanced hepatosplenic schistosomiasis: coincidence or connection?Human schistosomiasisEvaluation of the health-related quality of life of children in Schistosoma haematobium-endemic communities in Kenya: a cross-sectional study.Modeling the effect of chronic schistosomiasis on childhood development and the potential for catch-up growth with different drug treatment strategies promoted for control of endemic schistosomiasisDiagnostics for schistosomiasis in Africa and Arabia: a review of present options in control and future needs for elimination.Impact of drought on the spatial pattern of transmission of Schistosoma haematobium in coastal KenyaAge-Stratified Profiles of Serum IL-6, IL-10, and TNF-α Cytokines Among Kenyan Children with Schistosoma haematobium, Plasmodium falciparum, and Other Chronic Parasitic Co-Infections.Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy.Anemia Among Children Exposed to Polyparasitism in Coastal Kenya.Impact of polyparasitic infections on anemia and undernutrition among Kenyan children living in a Schistosoma haematobium-endemic area.Fecal occult blood and fecal calprotectin as point-of-care markers of intestinal morbidity in Ugandan children with Schistosoma mansoni infection.Schistosomiasis in African infants and preschool children: let them now be treated!Development of a specimen-sparing multichannel bead assay to detect antiparasite IgG4 for the diagnosis of Schistosoma and Wuchereria infections on the coast of Kenya.HIV and schistosomiasis co-infection in African children.Predictors of fever-related admissions to a paediatric assessment unit, ward and reattendances in a South London emergency department: the CABIN 2 study.A centenary of Robert T. Leiper's lasting legacy on schistosomiasis and a COUNTDOWN on control of neglected tropical diseases.One hundred years of neglect in paediatric schistosomiasis.Point-of-care tests for infectious diseases: barriers to implementation across three London teaching hospitals.Paediatric and maternal schistosomiasis: shifting the paradigms.Cognitive deficits and educational loss in children with schistosome infection-A systematic review and meta-analysis.Praziquantel for the treatment of schistosomiasis during human pregnancy.Schistosomiasis in Africa: Improving strategies for long-term and sustainable morbidity control.Schistosomiasis-associated pulmonary arterial hypertension: a systematic reviewA cross-sectional study of periportal fibrosis and Schistosoma mansoni infection among school-aged children in a hard-to-reach area of MadagascarFocused Assessment with Sonography for Urinary Schistosomiasis (FASUS)-pilot evaluation of a simple point-of-care ultrasound protocol and short training program for detecting urinary tract morbidity in highly endemic settingsImplementation of a Highly Accurate Rapid Point-of-Care Test for Group a Streptococcus Detection at a Large Pediatric Emergency Department in South LondonSchistosoma mansoni Infection as a Predictor of Low Aerobic Capacity in Ugandan ChildrenCould This Child Have Schistosomiasis?: When to Suspect It and What to Do About It
P50
Q28554319-E193BF2A-1FA5-4097-B3B5-49BE0C9DA577Q29247951-18DD2967-B49C-46AF-85F3-C6E063EB05FDQ30366003-6D3B4D43-EB0C-4F32-B046-AA7616E7D76AQ33831175-7E72CFC3-2B79-49A7-9D31-B936B33E7393Q33945650-D65D9657-5A30-43DC-97B0-E9CE22602BC2Q33959403-EEE667A0-16DD-4535-815B-B0768EC181B1Q34281635-3DFD8AE4-3792-4B8D-A8BC-257F4E4B96C6Q34413522-7FF62F0E-1246-4157-A6E7-3BAF9721276FQ34626132-C21C05E8-986B-4F2A-913B-090308F45483Q34875689-E5DF965E-8ED4-4B49-BEDD-6FF21EEB94AAQ35232240-4FEFE542-7F54-40E5-90D6-A9705D7C43DAQ35576044-B803AB48-890B-45E9-B810-57B2727A91A0Q35590773-1DBF590E-534C-4F0E-8076-60234CC49713Q36099895-C2EFDB87-A3B4-482C-8FE4-F3ECD30F5D12Q36436163-8E379AEE-3EF5-481C-BD37-AF5D6954B471Q36669072-7A808381-A31A-4552-AA0E-4849FC760D2BQ37308686-E688544A-EB2C-4814-973A-477F94F3E233Q37427116-FBC9EC02-6359-4D39-9CF0-FEF7DE41F117Q37680704-CF587184-AEFA-462E-BC75-B3EE1EFAD1BAQ38205649-68765F58-954C-4B69-8543-7286437770FEQ38828809-2B301299-C2C0-42CF-8462-DC716A77A845Q38854033-7DCC2498-6977-461D-A891-B660380D3FF8Q38927082-11AAD24F-8D6F-40DD-B15A-5FA9394C2675Q38927086-B49A97AB-9A5C-45AA-826C-F3A103D6988FQ40045772-5453133D-1603-4B3A-B89A-8D853266841FQ48252966-45052D11-4C3C-4D16-84AD-92FC8EB2DF7AQ50197822-48CD58BC-D54D-48FA-B3F0-4210F1D4FF72Q55472878-5CB70099-B10F-428A-9642-7A83139ABAAFQ89554945-4F40C84B-742F-417F-B1BD-3671DE03DBD2Q90385627-F615140D-9622-4CA7-8C66-471A18C8E571Q91313018-43822B99-DE7E-47C6-8073-6BEE55C100D2Q91923120-96FB3B8B-0E31-400E-99F3-FFFF9AD84FB3Q93148228-6936B735-912E-4705-B2CB-AAEA69EEC344Q94603975-DC87C6C3-A05F-4FEA-A4B8-AFA7D6E0BD54
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Amaya Bustinduy
@ast
Amaya Bustinduy
@en
Amaya Bustinduy
@es
Amaya Bustinduy
@nl
type
label
Amaya Bustinduy
@ast
Amaya Bustinduy
@en
Amaya Bustinduy
@es
Amaya Bustinduy
@nl
altLabel
Amaya L. Bustinduy
@en
prefLabel
Amaya Bustinduy
@ast
Amaya Bustinduy
@en
Amaya Bustinduy
@es
Amaya Bustinduy
@nl
P106
P21
P31
P496
0000-0001-6131-4159